Publication Name	World Journal of Clinical Oncology
Manuscript ID	20540
Country	Türkiye

Received	2015-06-09 16:24
Peer-Review Started	2015-06-14 18:26
To Make the First Decision	2015-09-16 09:10
Return for Revision	2015-09-17 17:12
Revised	2015-10-02 16:37
Second Decision	2015-11-17 15:13
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2015-12-02 14:16
Articles in Press	2015-12-02 14:16
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2016-01-18 11:39
Publish the Manuscript Online	2016-01-30 17:42

ISSN	2218-4333 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Editorial
Article Title	Current treatment options for patients with initially unresectable isolated colorectal liver metastases
Manuscript Source	Invited Manuscript
All Author List	Ozkan Kanat
Funding Agency and Grant Number
Corresponding Author	Ozkan Kanat, MD, PhD, Professor, Department of Medical Oncology, Uludag University Faculty of Medicine, Gorukle, 16059 Bursa, Turkey. ozkanat@uludag.edu.tr
Key Words	Colorectal cancer; Conversion therapy; Liver metastases; Targeted therapy; Hepatic arterial infusion
Core Tip	A subset of patients presenting with unresectable colorectal liver metastases (CLM) patients may become eligible for resection following systemic (chemotherapy ± biological therapy) and loco-regional treatments, including hepatic arterial infusion. After successful complete (R0) resection of liver lesions, these patients can achieve long-term survival. Therefore, all patients with CLM should be discussed in a multidisciplinary team meeting to identify appropriate treatment options.
Publish Date	2016-01-30 17:42
Citation	Kanat O. Current treatment options for patients with initially unresectable isolated colorectal liver metastases. World J Clin Oncol 2016; 7(1): 9-14
URL	http://www.wjgnet.com/2218-4333/full/v7/i1/9.htm
DOI	http://dx.doi.org/10.5306/wjco.v7.i1.9

Full Article (PDF)	WJCO-7-9.pdf
Full Article (Word)	WJCO-7-9.doc
Manuscript File	20540-Review.docx
Answering Reviewers	20540-Answering reviewers.pdf
Audio Core Tip	20540-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	20540-Conflict-of-interest statement.pdf
Copyright License Agreement	20540-Copyright assignment.pdf
Peer-review Report	20540-Peer-review(s).pdf
Scientific Misconduct Check	20540-Scientific misconduct check.pdf
Scientific Editor Work List	20540-Scientific editor work list.pdf